NORDICARE ORTOPEDI & REHAB AB
SE-263 62 VIKEN
Return on Equity
0,32 %
Current Ratio
2,38
Debt-to-Equity Ratio
0
Key figures (NOK) | 2022 | |
---|---|---|
Revenue | 11 284 000 | |
Net Income | 2 000 | |
Total Assets | 1 078 000 | |
Total Equity | 625 000 |
Income (NOK) | 2022 | |
---|---|---|
Revenue | 11 284 000 | |
Expenditure | 11 270 000 | |
Operating Profit | 13 000 | |
Financial Income | 4 000 | |
Financial Costs | 16 000 | |
Financial Balance | −12 000 | |
Earnings Before Tax | 2 000 | |
Tax | 0 | |
Net Income | 2 000 |
Balance (NOK) | 2022 | |
---|---|---|
Total Fixed Assets | 0 | |
Total Current Assets | 1 078 000 | |
Total Assets | 1 078 000 | |
Total Retained Equity | 625 000 | |
Total Equity | 625 000 | |
Total Long-Term Debt | 0 | |
Total Current Debt | 453 000 | |
Total Equity and Debt | 1 078 000 |
Cash flow (NOK) | 2022 | |
---|---|---|
Sales Income | 11 284 000 | |
Other Income | 0 | |
Revenue | 11 284 000 | |
Cost of Goods Sold | 11 001 000 | |
Salary Costs | 14 000 | |
Depreciation | 0 | |
Impairment | 0 | |
Expenditure | 11 270 000 | |
Operating Profit | 13 000 | |
Financial Income | 4 000 | |
Financial Costs | 16 000 | |
Financial Balance | −12 000 | |
Dividends | 0 | |
Net Income | 2 000 |
Balance details (NOK) | 2022 | |
---|---|---|
Goodwill | 0 | |
Total Intangible Assets | 0 | |
Real Eastate | 0 | |
Machinery and Plant Facilities | 0 | |
Fixtures | 0 | |
Total Tangible Assets | 0 | |
Total Fiancial Fixed Assets | 0 | |
Total Fixed Assets | 0 | |
Stock | 0 | |
Total Investments | 0 | |
Cash, Bank | 0 | |
Total Current Assets | 1 078 000 | |
Total Assets | 1 078 000 | |
Total Equity | 625 000 | |
Short-Term Group Debt | 0 | |
Total Long-Term Debt | 0 | |
Creditors | 0 | |
Unpaid Taxes | 437 000 | |
Dividends | 0 | |
Other Current Debt | 15 000 | |
Total Current Debt | 453 000 | |
Total Equity and Debt | 1 078 000 |
Financial indicators | 2022 | |
---|---|---|
Return on Equity | 0,32 % | |
Debt-to-Equity Ratio | 0 | |
Operating Profit Margin | 0,12 % | |
Current Ratio | 2,38 | |
Quick Ratio | 2,38 | |
Equity Ratio | 0,58 | |
Gross Profit Margin | 2,51 % |
Rotate your device to see the full table
More companies within Wholesale of pharmaceutical goods
NOBEL BIOCARE NORGE AS
VIND AS
P. OLANDER MEDICA AB
SKANDMED ANS
BROOKHAVEN INSTRUMENTS AB
ROCHE DIAGNOSTICS NORGE AS
SAFEDON NORGE AS
DMEDICAL AS
DECHRA VETERINARY PRODUCTS AS
QUALITY CARE AS
QIAGEN NORGE, FILIAL AV QIAGEN AB, SVERIGE
MEDIPLAST AS
ØVREBØ HOLDING AS
BRAGE MEDICAL AS
STEIN JACOBSEN INVEST AS
See all ->